Effect and therapeutic mechanisms of tonsillectomy for childhood IgA nephropathy

Nephrology

Volumn 17, Issue 7, 2012, Pages 658-664

  Nishi, Hitomi ^a   Sugimoto, Keisuke ^a   Fujita, Shinsuke ^a   Miyazaki, Kohei ^a   Miyazawa, Tomoki ^a   Sakata, Naoki ^a   Okada, Mitsuru ^a   Takemura, Tsukasa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

childhood IgA nephropathy; complement component C3; macrophages; proteinuria; tonsillectomy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MIZORIBINE; STEROID; WARFARIN;

ADOLESCENT; ANTICOAGULANT THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC TONSILLITIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; EARLY INTERVENTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MACROPHAGE ACTIVATION; MALE; PALATINE TONSILLITIS; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; PSORIASIS VULGARIS; REMISSION; SCHOOL CHILD; TONSILLECTOMY;

ADOLESCENT; BIOPSY; CASE-CONTROL STUDIES; CHILD; COMPLEMENT C3; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; MACROPHAGE ACTIVATION; MALE; PROTEINURIA; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TONSILLECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865837967     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01620.x     Document Type: Article

References (25)

1. Donadio JV, Grande JP,. IgA nephropathy. N. Engl. J. Med. 2002; 347: 738-48. (Pubitemid 35203906)
2. Suzuki S, Nakatomi Y, Sato H, Tsukada H, Arakawa M,. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 1994; 343: 12-6.
3. Koyama A, Sharmin S, Sakurai H, et al,. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 2004; 66: 121-32. (Pubitemid 38870088)
4. Coppo R,. Pediatric IgA nephropathy: Clinical and therapeutic perspectives. Semin. Nephrol. 2008; 28: 18-26.
5. Oortwijn BD, Rastaldi MP, Roos A, Mattinzoli D, Daha MR, van Kooten C,. Demonstration of secretory IgA in kidneys of patients with IgA nephropathy. Nephrol. Dial. Transplant. 2007; 22: 3191-5. (Pubitemid 350202542)
6. Ito T, Waga S, Tanaka H, Tateyama T, Yokoyama M,. Contribution of macromolecular IgA1 to IgA abnormality in IgA nephropathy. Pediatr. Nephrol. 2000; 15: 90-5.
7. Hotta O,. Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy. Semin. Nephrol. 2004; 24: 244-55. (Pubitemid 38685993)
8. Mariotti AJ, Agrawal R, Hotaling AJ,. The role of tonsillectomy in pediatric IgA nephropathy. Arch. Otolaryngol. Head Neck Surg. 2009; 135: 85-7.
9. Tomino Y,. Japanese guidelines for IgA nephropathy. Jpn. J. Nephrol. 2002; 44: 487-93.
10. Shiraishi S, Tomoda K, Matsumoto A, Kyomoto R, Yamashita T,. Investigation of the local provocation test to PPP and IgA nephritis. Acta Otolaryngol Suppl. 1996; 523: 178-81. (Pubitemid 26130576)
11. Jiang L, Liu G, Lv J, Huang C, et al,. Concise semiquantitative histological scoring system for immunoglobulin A nephropathy. Nephrology (Carlton) 2009; 14: 597-605.
12. Sugimoto K, Takemura Y, Yanagida H, et al,. Renal tubular dysgenesis and tubulointerstitial nephritis antigen in juvenile nephronophthisis. Nephrology (Carlton) 2011; 16: 495-501.
13. van den Berg JG, Weening JJ,. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin. Sci. 2004; 107: 125-36. (Pubitemid 39070928)
14. Huang H, Peng Y, Liu H, Yang X, Liu F,. Decreased CD4+CD25+ cells and increased dimeric IgA-producing cells in tonsils in IgA nephropathy. J. Nephrol. 2010; 23: 202-9.
15. Yoshikawa N, Ito H, Sakai T, et al,. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J. Am. Soc. Nephrol. 1999; 10: 101-9. (Pubitemid 29034948)
16. Tomino Y,. Treatment for IgA nephropathy [Review]. Contrib. Nephrol. 2007; 157: 8-12.
17. Ueda S, Takahara M, Tohtani T, Yoshizaki T, Kishibe K, Harabuchi Y,. Up-regulation of β1 integrin on tonsillar T cells and its induction by in vitro stimulation with α-streptococci in patients with pustulosis Palmaris et Plantaris. J. Clin. Immunol. 2010; 30: 861-71.
18. Shido F, Hamamoto M, Kukuminato Y, Kataura A,. On arthropathy with special reference to sternocostoclavicular hyperostosis. Adv. Otorhinolaryngol 1992; 47: 208-12.
19. Kamei K, Nakanishi K, Ito S, et al,. Japanese Pediatric IgA Nephropathy Treatment Study Group. Long-term results of a randomized controlled trial in childhood IgA nephropathy. Clin. J. Am. Soc. Nephrol. 2011; 6: 1301-7.
20. Xie Y, Nishi S, Ueno M, et al,. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003; 63: 1861-67. (Pubitemid 36513334)
21. Wang Y, Chen J, Wang Y, Chen Y, Wang L, Lv Y,. A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol. Dial. Transplant. 2011; 26: 1923-31.
22. Chen Y, Tang Z, Wang Q, et al,. Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy. Am. J. Nephrol. 2007; 27: 170-5. (Pubitemid 46588183)
23. Kawasaki Y, Takano K, Suyama K, et al,. Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy. Pediatr. Nephrol. 2006; 21: 1701-06. (Pubitemid 44390836)
24. Kawasaki Y, Suyama K, Abe Y, et al,. Tonsillectomy with methylprednisolone pulse therapy as rescue treatment for steroid-resistant IgA nephropathy in children. Tohoku J. Exp. Med. 2009; 218: 11-16.
25. Miyamoto H, Yoshioka K, Takemura T, Akano N, Maki S,. Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy. Virchows Arch. A. Pathol Anat Histopathol. 1998; 413: 77-86.